Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.325 USD | +0.38% | -6.03% | -32.74% |
05-13 | Ikena Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-12 | Ikena Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.74% | 63.7M | |
+27.47% | 48.16B | |
-0.94% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.22% | 25.59B | |
-22.89% | 18.96B | |
+7.89% | 12.92B | |
+29.29% | 12.03B | |
-2.21% | 11.77B |
- Stock Market
- Equities
- IKNA Stock
- News Ikena Oncology, Inc.
- Credit Suisse Adjusts Ikena Oncology's Price Target to $16 From $18, Keeps Outperform Rating